McArthur, G A <br/><br/>
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  03 2017 
 - 634-641 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdw641  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Brain Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Mutation<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome<br/>Vemurafenib